Approved reimbursement uses for the device include wound care, soft tissue replacement as in burn repair, cardiovascular applications, treatment and ocular surfaces and surgical barrier application in knee and spine surgeries, according to a news release.
At this time, 12 state Medicaid programs also reimburse for EpiFix, according to the release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
